pOTTC1328 - pAAV EF1a HA-hM3D(Gq) Citations (2)

Originally described in: Chemogenetics revealed: DREADD occupancy and activation via converted clozapine.
Gomez JL, Bonaventura J, Lesniak W, Mathews WB, Sysa-Shah P, Rodriguez LA, Ellis RJ, Richie CT, Harvey BK, Dannals RF, Pomper MG, Bonci A, Michaelides M Science. 2017 Aug 4;357(6350):503-507. doi: 10.1126/science.aan2475. PubMed Journal

---

Articles Citing pOTTC1328 - pAAV EF1a HA-hM3D(Gq)

Articles
High-potency ligands for DREADD imaging and activation in rodents and monkeys. Bonaventura J, Eldridge MAG, Hu F, Gomez JL, Sanchez-Soto M, Abramyan AM, Lam S, Boehm MA, Ruiz C, Farrell MR, Moreno A, Galal Faress IM, Andersen N, Lin JY, Moaddel R, Morris PJ, Shi L, Sibley DR, Mahler SV, Nabavi S, Pomper MG, Bonci A, Horti AG, Richmond BJ, Michaelides M. Nat Commun. 2019 Oct 11;10(1):4627. doi: 10.1038/s41467-019-12236-z. PubMed
(18)F-labeled radiotracers for in vivo imaging of DREADD with positron emission tomography. Hu F, Morris PJ, Bonaventura J, Fan H, Mathews WB, Holt DP, Lam S, Boehm M, Dannals RF, Pomper MG, Michaelides M, Horti AG. Eur J Med Chem. 2021 Mar 5;213:113047. doi: 10.1016/j.ejmech.2020.113047. Epub 2020 Nov 25. PubMed

If you have published an article using this material, please email us at to have your article added to this page.